Activation of Protease-Activated Receptor 2 Induces VEGF Independently of HIF-1

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Rasmussen, Jeppe Grøndahl ^a,b   Riis, Simone Elkjær ^b   Frøbert, Ole ^c   Yang, Sufang ^b,d   Kastrup, Jens ^e   Zachar, Vladimir ^b   Simonsen, Ulf ^a   Fink, Trine ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d GUANGXI UNIVERSITY   (China)

^e Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEINASE ACTIVATED RECEPTOR 2; TRYPSIN; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ADULT; ARTICLE; CASE REPORT; CELL HYPOXIA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN SECRETION; RECEPTOR BLOCKING; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE; WESTERN BLOTTING;

ADIPOSE TISSUE; ADULT; CELL HYPOXIA; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOBLOTTING; MALE; MIDDLE AGED; OXYGEN; POLYMERASE CHAIN REACTION; RECEPTOR, PAR-2; STEM CELLS; TRYPSIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866705655     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046087     Document Type: Article

References (34)

1. Bai X, Alt E, (2010) Myocardial regeneration potential of adipose tissue-derived stem cells. Biochemical and biophysical research communications 401: 321-326.
2. Miranville A, Heeschen C, Sengenès C, Curat CA, Busse R, et al. (2004) Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110: 349-355.
3. Zachar V, Duroux M, Emmersen J, Rasmussen JG, Pennisi CP, et al. (2011) Hypoxia and adipose-derived stem cell-based tissue regeneration and engineering. Expert opinion on biological therapy 11: 775-786.
4. Rasmussen JG, Frøbert O, Pilgaard L, Kastrup J, Simonsen U, et al. (2011) Prolonged hypoxic culture and trypsinization increase the pro-angiogenic potential of human adipose tissue-derived stem cells. Cytotherapy 13: 318-328.
5. Sadat S, Gehmert S, Song Y-H, Yen Y, Bai X, et al. (2007) The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochemical and biophysical research communications 363: 674-679.
6. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, et al. (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109: 1292-1298.
7. Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, et al. (2010) Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock (Augusta, Ga) 33: 24-30.
8. Wang X, Zhao T, Huang W, Wang T, Qian J, et al. (2009) Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem cells (Dayton, Ohio) 27: 3021-3031.
9. Liu Y, Mueller BM, (2006) Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochemical and biophysical research communications 344: 1263-1270.
10. Zhu T, Sennlaub F, Beauchamp MH, Fan L, Joyal JS, et al. (2006) Proangiogenic effects of protease-activated receptor 2 are tumor necrosis factor-alpha and consecutively Tie2 dependent. Arteriosclerosis, thrombosis, and vascular biology 26: 744-750.
11. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and cellular biology 16: 4604-4613.
12. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J, (1994) Molecular cloning of a potential proteinase activated receptor. Proceedings of the National Academy of Sciences of the United States of America 91: 9208-9212.
13. Déry O, Thoma MS, Wong H, Grady EF, Bunnett NW, (1999) Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor. The Journal of biological chemistry 274: 18524-18535.
14. Vu TK, Hung DT, Wheaton VI, Coughlin SR, (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1068.
15. Greenberg DL, Mize GJ, Takayama TK, (2003) Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells. Biochemistry 42: 702-709.
16. Kawabata A, Saifeddine M, Al-Ani B, Leblond L, Hollenberg MD, (1999) Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. The Journal of pharmacology and experimental therapeutics 288: 358-370.
17. Tanaka Y, Sekiguchi F, Hong H, Kawabata A, (2008) PAR2 triggers IL-8 release via MEK/ERK and PI3-kinase/Akt pathways in GI epithelial cells. Biochemical and biophysical research communications 377: 622-626.
18. Yagi Y, Otani H, Ando S, Oshiro A, Kawai K, et al. (2006) Involvement of Rho signaling in PAR2-mediated regulation of neutrophil adhesion to lung epithelial cells. European journal of pharmacology 536: 19-27.
19. Dutra-Oliveira A, Monteiro RQ, Mariano-Oliveira A, (2012) Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines. Biochemical and biophysical research communications 421: 221-227.
20. Camerer E, Barker A, Duong DN, Ganesan R, Kataoka H, et al. (2010) Local protease signaling contributes to neural tube closure in the mouse embryo. Developmental cell 18: 25-38.
21. Brahimi-Horn MC, Pouysségur J, (2009) HIF at a glance. Journal of cell science 122: 1055-1057.
22. Leung K-W, Ng H-M, Tang MKS, Wong CCK, Wong RNS, et al. (2011) Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis. Angiogenesis 14: 515-522.
23. Jing Y, Liu L-Z, Jiang Y, Zhu Y, Guo NL, et al. (2012) Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells. Toxicological sciences: an official journal of the Society of Toxicology 125: 10-19.
24. Uusitalo-Jarvinen H, Kurokawa T, Mueller BM, Andrade-Gordon P, Friedlander M, et al. (2007) Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis. Arteriosclerosis, thrombosis, and vascular biology 27: 1456-1462.
25. Svensson KJ, Kucharzewska P, Christianson HC, Sköld S, Löfstedt T, et al. (2011) Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 108: 13147-13152.
26. Pilgaard L, Lund P, Rasmussen JG, Fink T, Zachar V, (2008) Comparative analysis of highly defined proteases for the isolation of adipose tissue-derived stem cells. Regenerative medicine 3: 705-715.
27. Fink T, Rasmussen JG, Lund P, Pilgaard L, Soballe K, et al. (2011) Isolation and expansion of adipose-derived stem cells for tissue engineering. Frontiers in bioscience (Elite edition) 3: 256-263.
28. Pilgaard L, Lund P, Duroux M, Fink T, Ulrich-Vinther M, et al. (2009) Effect of oxygen concentration, culture format and donor variability on in vitro chondrogenesis of human adipose tissue-derived stem cells. Regenerative medicine 4: 539-548.
29. Fink T, Lund P, Pilgaard L, Rasmussen JG, Duroux M, et al. (2008) Instability of standard PCR reference genes in adipose-derived stem cells during propagation, differentiation and hypoxic exposure. BMC molecular biology 9: 98.
30. Fink T, Zachar V, (2011) Adipogenic differentiation of human mesenchymal stem cells. Methods in molecular biology (Clifton, NJ) 698: 243-251.
31. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
32. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Molecular biology of the cell 13: 4279-4295.
33. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, et al. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer research 60: 1541-1545.
34. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, et al. (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. The Journal of biological chemistry 277: 38205-38211.